Verrica Pharmaceuticals (VRCA) Return on Sales (2021 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Return on Sales of 0.02% for Q1 2026, up 1.0% year-over-year from 0.02% in Q1 2025, and down 3.02% quarter-over-quarter from 0.02% in Q4 2025.
Verrica Pharmaceuticals (VRCA) Return on Sales (2021 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Return on Sales history runs 6 years deep, the most recent figure standing at 0.02% for Q1 2026.
- In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.01% (up 6.0% YoY), while the FY2025 annual figure was 0.02%, up 16.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.02%, down from 0.02% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q3 2022, with the low at 7.08% in Q1 2024.
- The 5-year median for Return on Sales is 0.12% (2023), against an average of 0.77%.
- The sharpest annual moves came in 2024 and 2025: Return on Sales plunged 413 bps in 2024, then soared 705 bps in 2025.
- Verrica Pharmaceuticals' Return on Sales stood at 0.93% in 2022, then surged by 87 bps to 0.12% in 2023, then sank by 209 bps to 0.38% in 2024, then surged by 95 bps to 0.02% in 2025, then dropped by 3 bps to 0.02% in 2026.
- Business Quant data shows VRCA's Return on Sales at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.00% |
| 10 | Verrica Pharmaceuticals | 101.41 Mn | 90.21 Mn | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.38% |
| Sep 30, 2024 | -0.17% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -7.08% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.60% |
| Mar 31, 2023 | -2.94% |
| Dec 31, 2022 | -0.93% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.49% |
| Mar 31, 2022 | -0.20% |
| Dec 31, 2021 | -0.04% |
| Mar 31, 2021 | 0.00% |